Methylphenidate

BreastfeedingGeriatric
  • TRADE NAMES: Centedrin; Concerta (Janssen); Cotempla; Daytrana; Metadate CD (Celltech); Methylin (Mallinckrodt); Rilatine; Ritalin (Novartis); Rubifen
  • INDICATIONS: Attention deficit disorder, narcolepsy
  • CLASS: Amphetamine
  • HALF-LIFE: 2–4 hours
ABUSE AND DEPENDENCE

See full prescribing information for complete boxed warning.

Our database has 104 adverse reactions for this drug across the following areas

Please login to see the rest of this drug profile


Not a subscriber? Click here to subscribe

SKIN
MUCOSAL
CARDIOVASCULAR
CENTRAL NERVOUS SYSTEM
NEUROMUSCULAR/SKELETAL
GASTROINTESTINAL/HEPATIC
RESPIRATORY
ENDOCRINE/METABOLIC
GENITOURINARY
RENAL
OTIC
OCULAR
LOCAL
OTHER


Page last updated 10/09/2017

Drug Eruption Mobile Site

Symbol key

Incidence info

  • <1%
  • 1-5%
  • 5-10%
  • 10-15%
  • 15-20%
  • 20-30%
  • >30%

Seriousness info

  • Hospitalization possible
  • Life threatening
  • Fatal

Warnings in other populations info

  • Breast feeding
  • Geriatric
  • Pediatric